Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

8.14
Delayed Data
As of Feb 11
 -0.07 / -0.85%
Today’s Change
5.42
Today|||52-Week Range
19.23
-37.05%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close8.21
Today’s open8.06
Day’s range7.90 - 8.38
Volume62,913
Average volume (3 months)181,196
Market cap$149.9M
Dividend yield--
Data as of 02/11/2016

Growth & Valuation

Earnings growth (last year)-11.11%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.98

Competitors

 Today’s
change
Today’s
% change
NEOSNeos Therapeutics In...-0.68-7.26%
ACRXAcelRx Pharmaceutica...-0.08-2.35%
--China Health Group I...-0.00-0.62%
ADHDAlcobra Ltd+0.12+2.30%
Data as of 02/11/2016

Financials

Next reporting dateMarch 9, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
Chief Financial Officer, Secretary, CAO &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts

Partner Offers